₹963.1
▼ -13.08 -1.34%
17 Jul 2026
NSE Listed
Fortis Healthcare Ltd. (FORTIS)
Volume: 11,63,956Avg Vol 1W: 13,64,379.2Avg Vol 1M: 16,77,983.3552W Range:₹766.8₹1,104.3
Key Ratios
Checked 20h agoMarket Cap₹73,695 Cr
Current Price₹963.1
Previous Close₹976.18
High / Low (52w)₹1,104.3 / ₹766.8
Volume11,63,956
Avg Vol (1W)13,64,379.2
Avg Vol (1M)16,77,983.35
Stock P/E277.32
Book Value₹131.07
Dividend Yield0.1%
ROE10.5%
ROA6.7%
Revenue (TTM)₹7,850 Cr
Revenue Growth12.9%
Profit Margin11.4%
Total Debt₹2,086 Cr
Shares Outstanding75 Cr
Face Value₹10
EPS (TTM)₹3.52
P/B7.45
Debt / Equity0.35
50 DMA₹964.05
200 DMA₹929.59
Day change-1.34%
Price Chart
₹963.1▲ 21.12% · 1Y
2025-07-162026-07-15
20-day avg volume: 16.8L shares
Pros
- Company is almost debt-free.
Cons
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 277.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,859 Cr | ₹1,988 Cr | ₹1,928 Cr | ₹2,007 Cr | ₹2,167 Cr | ₹2,331 Cr | ₹2,265 Cr | ₹2,365 Cr |
| EBITDA | ₹265 Cr | ₹353 Cr | ₹299 Cr | ₹353 Cr | ₹405 Cr | ₹473 Cr | ₹394 Cr | ₹415 Cr |
| Net Profit | ₹166 Cr | ₹176 Cr | ₹248 Cr | ₹184 Cr | ₹260 Cr | ₹322 Cr | ₹194 Cr | ₹266 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4,701 Cr | ₹4,562 Cr | ₹4,685 Cr | ₹4,077 Cr | ₹5,745 Cr | ₹6,359 Cr | ₹6,931 Cr | ₹7,850 Cr |
| EBITDA | ₹174 Cr | ₹85 Cr | ₹370 Cr | ₹160 Cr | ₹795 Cr | ₹847 Cr | ₹963 Cr | ₹1,269 Cr |
| Net Profit | ₹-1,009 Cr | ₹-299 Cr | ₹58 Cr | ₹-110 Cr | ₹555 Cr | ₹589 Cr | ₹599 Cr | ₹774 Cr |
| EPS | -19.46 | -4.91 | 0.77 | -1.45 | 7.35 | 7.8 | 7.93 | 10.26 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹8,622 Cr | ₹11,951 Cr | ₹11,348 Cr | ₹11,155 Cr | ₹11,885 Cr | ₹12,434 Cr | ₹13,289 Cr | ₹13,692 Cr |
| Total Liabilities | ₹3,305 Cr | ₹4,839 Cr | ₹4,142 Cr | ₹4,437 Cr | ₹4,876 Cr | ₹4,333 Cr | ₹4,733 Cr | ₹4,522 Cr |
| Equity | ₹5,317 Cr | ₹7,112 Cr | ₹7,206 Cr | ₹6,718 Cr | ₹7,008 Cr | ₹8,100 Cr | ₹8,556 Cr | ₹9,169 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹513 Cr | ₹69 Cr | ₹511 Cr | ₹438 Cr | ₹1,077 Cr | ₹1,096 Cr | ₹1,322 Cr | ₹1,534 Cr |
| Investing | ₹-335 Cr | ₹-3,323 Cr | ₹60 Cr | ₹-135 Cr | ₹-514 Cr | ₹-374 Cr | ₹-886 Cr | ₹-779 Cr |
| Financing | ₹-672 Cr | ₹4,257 Cr | ₹-862 Cr | ₹-143 Cr | ₹-517 Cr | ₹-471 Cr | ₹-86 Cr | ₹-714 Cr |
| Free Cash Flow | ₹513 Cr | ₹69 Cr | ₹511 Cr | ₹438 Cr | ₹1,077 Cr | ₹1,096 Cr | ₹1,322 Cr | ₹1,534 Cr |
Shareholding
Promoter 31.17% Institutions 57.33% Public 11.51%
Efficiency & Working Capital
ROCE12.6%
Interest Coverage6.5
Dividend Payout—
Debtor Days37 d
Inventory Days5 d
Payable Days38 d
Cash Conversion Cycle4 d
Working Capital Days42 d
Shareholding Details
As of 2026-03-31
Promoter31.2%
FII26%
DII31.4%
Institutions57.3%
Public11.5%
Promoter Pledge0%
No. of Shareholders2,26,685
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% |
| FIIs | 30% | 26.3% | 23.7% | 23.2% | 23.3% | 25.3% | 26.8% | 27.4% | 27.2% | 27.9% | 27.8% | 26% |
| DIIs | 22.2% | 26.5% | 29.3% | 31.2% | 32.3% | 30.7% | 30.1% | 29.5% | 29.8% | 29.1% | 29.3% | 31.4% |
| Public | 16.6% | 16% | 15.8% | 14.4% | 13.2% | 12.8% | 12% | 12% | 11.9% | 11.8% | 11.7% | 11.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,35,047 | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 | 2,18,329 | 2,05,373 | 2,20,766 | 2,33,156 | 2,26,685 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Northern Tk Venture Pte. Ltd. | Shareholding of Promoter and Promoter Group | 31.2% | 23.53 Cr |
| Hdfc Mutual Fund - Hdfc Nifty Midcap 150 Index Fun | Public Shareholding | 6.5% | 4.87 Cr |
| Kotak Large & Midcap Fund | Public Shareholding | 5.7% | 4.30 Cr |
| Rekha Jhunjhunwala | Public Shareholding | 4% | 3.04 Cr |
| Axis Mutual Fund Trustee Ltd. A/c Axis Mutual Fund | Public Shareholding | 2.8% | 2.12 Cr |
| Nippon Life India Trustee Ltd- A/c Nippon India Vi | Public Shareholding | 2.4% | 1.83 Cr |
| Amansa Holdings Private Limited | Public Shareholding | 1.6% | 1.21 Cr |
| Sbi Life Insurance Co. Ltd | Public Shareholding | 1.6% | 1.19 Cr |
| Dsp Nifty Midcap 150 Index Fund | Public Shareholding | 1.4% | 1.06 Cr |
| Aditya Birla Sun Life Trustee Private Limited A/c | Public Shareholding | 1.3% | 98,44,476 |
| Jupiter India Fund | Public Shareholding | 1.3% | 95,40,707 |
| Fidelity Funds - India Focus Fund | Public Shareholding | 1.2% | 93,40,251 |
| Edelweiss Trusteeship Co Ltd Ac- Edelweiss Mf Ac- | Public Shareholding | 1.2% | 92,09,340 |
| Axis Bank Limited | Public Shareholding | 1.2% | 90,00,000 |
| Kotak Funds - India Midcap Fund | Public Shareholding | 1.2% | 86,85,411 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Northern Tk Venture Pte. Ltd. | 0 | 0% | 2026-03-31 |
| Axis Mutual Fund Trustee Ltd. A/c Axis Mutual Fund | 0 | 0% | 2026-03-31 |
| Nippon Life India Trustee Ltd- A/c Nippon India Vi | 0 | 0% | 2026-03-31 |
| Kotak Large & Midcap Fund | 0 | 0% | 2026-03-31 |
| Hdfc Mutual Fund - Hdfc Nifty Midcap 150 Index Fun | 0 | 0% | 2026-03-31 |
| Aditya Birla Sun Life Trustee Private Limited A/c | 0 | 0% | 2026-03-31 |
| Dsp Nifty Midcap 150 Index Fund | 0 | 0% | 2026-03-31 |
| Edelweiss Trusteeship Co Ltd Ac- Edelweiss Mf Ac- | 0 | 0% | 2026-03-31 |
| Axis Bank Limited | 0 | 0% | 2026-03-31 |
| Sbi Life Insurance Co. Ltd | 0 | 0% | 2026-03-31 |
| Jupiter India Fund | 0 | 0% | 2026-03-31 |
| Fidelity Funds - India Focus Fund | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ashutosh Raghuvanshi | Managing Director & CEO | 2025 |
| DILIP KADAMBI | Non-Exec & Non-Independent Dir | 2025 |
| Indrajit Banerjee | Independent Non Exe. Director | 2025 |
| Shailaja Chandra | Independent Non Exe. Director | 2025 |
| Tomo Nagahiro | Non-Exec & Non-Independent Dir | 2025 |
| Mehmet Ali Aydinlar | Non Executive Director | 2025 |
| Lim Tsin Lin | Non-Exec & Non-Independent Dir | 2025 |
| Ashok Pandit | Non-Exec & Non-Independent Dir | 2025 |
| Prem Kumar Nair | Non-Exec & Non-Independent Dir | 2025 |
| Leo Puri | Chairman & Independent Directo | 2025 |
| Keith Hsiu Chin Lim | Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Healthcare services | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,446 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 850 | 755 | 755 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-07-25 | ₹1 (10%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 12,708 | 0 | 0 | 23 | 2 | 12,733 |
| 2025 | 12,164 | 0 | 0 | 0 | 2 | 12,166 |
| 2025 | 365 | 0 | 0 | 23 | 0 | 387 |
Substantial Acquisitions (SAST)
3 disclosure(s)
Market20/12/2024 · 1,51,95,198
Market02/08/2024 · 7,28,188
Market19/03/2024 · 20,15,481
Company Information
Incorporated1996
ChairmanLeo Puri
AuditorB S R & Co LLP
Investor Email[email protected]; contactus@fortis
📍 Fortis Hospital Sector-62, Phase-VIII, Mohali, Punjab, 160062
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search